Received May 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
The physician received the CAPVAXIVE and reports that during administration, it "really burned and stung".; HCP reports also having some redness around the affected arm; he also felt like he had flu-like symptoms the next day; and also where the shot was administered turned "a little purplish".; Indication: Pneumonia; This spontaneous report was received from a physician regarding himself, a male patient of unknown age. No information regarding the patient's pertinent medical history, drug reactions or allergies, or concomitant therapies was provided. On an unknown date in 2026 (reported as one or two months ago), the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) (dose, route of administration, anatomical location, lot number and expiration date not reported), for pneumonia (Product use in unapproved indication). On an unknown date in 2026, during administration, the patient felt burning and stung sensation (Vaccination site pain), he mentioned that he felt like he had flu-like symptoms the next day (Influenza like illness), the vaccination arm was redness (Vaccination site erythema) and turned "a little purplish" (Vaccination site discolouration). At the reporting time, the outcome of the events was unknown. The causal relationship between the events and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was not provided.